SCHEMBL19486252

SCHEMBL19486252

CCCOc1ccc(C(=N)NCC(=O)O)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLK1 P53350 1/20 0.55
LMNA P02545 3/20 0.55
ALDH1A1 P00352 1/20 0.55
L3MBTL1 Q9Y468 2/20 0.51
MAPT P10636 2/20 0.51
NPC1 O15118 1/20 0.51
NFKB1 P19838 1/20 0.51
RAB9A P51151 1/20 0.51
NFKB2 Q00653 1/20 0.51
RELA Q04206 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
MMP1 P03956 1/20 0.48
TSHR P16473 2/20 0.48
TP53 P04637 1/20 0.48
CHRNB2 P17787 1/20 0.47
CHRNB4 P30926 1/20 0.47
CHRNA3 P32297 1/20 0.47
CHRNA4 P43681 1/20 0.47
ITGB3 P05106 1/20 0.47
ITGA2B P08514 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19486257 0.94 ALDH1A1 (0.62) LMNAALDH1A1NPC1RAB9AMMP1
SCHEMBL835053 0.85 PLK1 (0.67) PLK1LMNAALDH1A1MAPTNPC1
SCHEMBL19481624 0.85 ALDH1A1 (0.45) LMNAALDH1A1L3MBTL1MAPTNPC1
SCHEMBL15149874 0.84 ITGB3 (0.49) LMNAALDH1A1MAPTRAB9ATSHR
SCHEMBL12894669 0.79 MMP1 (0.74) PLK1LMNAALDH1A1MAPTNPC1
SCHEMBL27543472 0.78 PPARA (0.51) LMNAL3MBTL1MMP1TSHRTP53
SCHEMBL3275310 0.78 PLK1 (0.56) PLK1L3MBTL1MAPTSMN1; SMN2MMP1
SCHEMBL19486142 0.78 PLK1 (0.49) PLK1ALDH1A1L3MBTL1MAPTNPC1
Hydrochloric Acid SCHEMBL7753379 0.77 PPARA (0.50) LMNAL3MBTL1MMP1TSHRTP53
SCHEMBL19486507 0.77 L3MBTL1 (0.48) PLK1L3MBTL1MAPTNPC1NFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170298057-A1 DEUTERATED O-SULFATED BETA LACTAM HYDROXAMIC ACIDS AND DEUTERATED N- SULFATED BETA LACTAMS ARIXA PHARMACEUTICALS, INC. 2017-10-19 US disclosed
WO-2017180794-A1 DEUTERATED O-SULFATED BETA-LACTAM HYDROXAMIC ACIDS AND DEUTERATED N-SULFATED BETA-LACTAMS SKYLINE ANTIINFECTIVES, INC. (US) 2017-10-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170298057-A1 DEUTERATED O-SULFATED BETA LACTAM HYDROXAMIC ACIDS AND DEUTERATED N- SULFATED BETA LACTAMS DDOST, LBR, STS PLK1 1675/4885LMNA 1805/4885ALDH1A1 3218/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.